Diphtheria toxoid-specific CD4+ T-helper cell (DT-specific CD4+ T cell)

Diphtheria toxoid-specific CD4+ T-helper cells are a specialized subset of the adaptive immune system that recognize peptides derived from the diphtheria toxoid (DT) or its non-toxic variant CRM197 (Diethelm-Okita et al., 2000). These peptides are processed by antigen-presenting cells and presented on MHC class II molecules, primarily HLA-DR, to the T-cell receptor (TCR) of the helper T cell (Novak et al., 1999). Upon activation, these cells proliferate and secrete cytokines such as interleukin-2 and interferon-gamma, which are crucial for orchestrating a robust immune response. Their primary therapeutic role is as a target for conjugate vaccines, where the toxoid acts as a carrier protein to provide T-cell help for B-cell activation against linked antigens, such as bacterial polysaccharides (NIH, 2024). This interaction is essential for inducing high-affinity antibody production and long-term immunological memory against pathogens like Haemophilus influenzae and Streptococcus pneumoniae. Additionally, these cells are being explored in cancer immunotherapy to enhance the immunogenicity of tumor-associated antigens, such as MUC1 (ACS Pharmacol Transl Sci, 2024). Safety considerations include potential hypersensitivity to the toxoid and carrier-induced epitopic suppression, which can limit the effectiveness of subsequent vaccinations.

Other names

Diphtheria toxoid-reactive CD4+ T cellCRM197-specific T-helper cellDT-specific T-helper cellT-helper cells recognizing DT331-345

Activation of the T-cell receptor (TCR) through recognition of diphtheria toxoid-derived peptides presented on MHC class II molecules, leading to T-cell proliferation and cytokine-mediated B-cell help.